Consistent with these findings, increased levels of peroxiredoxin-6 have been reported in the brain tissues of amyloid transgenic mouse models (Guerreiro et al., 2008) and AD patients (Sultana et al., 2007; Power et al., 2008). This evidence concerns the gene PRDX6 and Alzheimer disease.